Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster
  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Mid and smallcaps in favour today
Mon, 1 Apr 01:30 pm

Indian stock markets lost the initial gains and are hovering around the dotted line during the post noon trading session. Selling pressure is being witnessed in stocks from the metal and auto sectors while realty and capital goods sector are seeing maximum buying interest.

BSE-Sensex is up 7 points and NSE-Nifty is trading up by 10 points. While BSE Mid Cap is trading up by 0.74%, BSE Small Cap index is trading up by 1.54%. The rupee is trading at 54.28 to the US dollar.

Most of the domestic pharma stocks are trading in the green with Dishman Pharma and Indoco Remedies being among the leading gainers. As per a leading daily, the Indian Supreme court dismissed Swiss based company Novartis AG's petition seeking patent for its cancer drug Glivec. The Supreme Court upheld an earlier verdict given by the tribunal court and Indian patent law. As per the judgment the said drug failed the test for innovation as specified under the Patent Act. Novartis has filed various litigations in Indian courts since 2006 to get a patent for Glivec in India. Indian law has refused to grant it a patent as it does not consider Glivec a new molecule and deems the drug is only an amended version of a known compound. The drug is sold by Cipla and Natco Pharma in Indian markets. The decision is favorable to both the companies. Cipla was trading up by 2.5%.

Majority of the hotel stocks are trading in the green with Country Club and Hotel LeelaVenture being the biggest gainers. Taj GVK and Oriental Hotels are trading in the red. As per a leading financial daily, the hotel industry is expected to receive a big push if the government proposal to extend 'infrastructure status' to hotel projects with outlay of over Rs 2.5 bn sails through. This will enable the industry to access long term funding at lower interest rates. Currently, only three-star and higher category hotels located outside cities with population of over 10 lakh are eligible as infrastructure projects for bank finance. According to the Federation of Hotel and Restaurant Associations of India (FHRAI), 95% of the hotels were outside the ambit of this provision. Consequently, a number of hotel projects have been shelved or have changed their business model due to piling up of debt. The relaxation in rules will enable hotels to access 15-year loans as well as infrastructure bonds issued by finance companies. FHRAI expects the notification to this effect to come up in the next two months. Recently, the Reserve Bank of India (RBI) had permitted hotel companies access to external commercial borrowings for project size of Rs 2.5 bn or more.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Equitymaster requests your view! Post a comment on "Mid and smallcaps in favour today". Click here!


Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


Feb 21, 2018 (Close)